Janssen-Cilag G.m.b.H Clinical Trials
Sponsors / Janssen-Cilag G.m.b.H
ClinicalTrials.gov lists 16 trials for which Janssen-Cilag G.m.b.H is named as lead sponsor. The portfolio currently includes 1 recruiting studies, 2 active non-recruiting studies, and 8 completed studies. 4 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 5,653 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
16
Total Trials
1
Recruiting
2
Other Active
8
Completed
4
Terminated / Withdrawn
5,653
Total Enrollment
Termination reasons: Other75% · Recruitment25%
Recent Terminations
- Anogenital Cancer"Organizational reasons"
- Schizophrenia
- Postoperative Pain"The study was prematurely discontinued since study medication was no longer available."
- Lymphoma, Follicular"Recruitment too slow"
Active Trials (2 total)
- NCT07102368
- Multiple Myeloma PHASE2NCT04656951
- NCT04842591